US Surgical ends bid for Circon:
This article was originally published in Clinica
As expected, US Surgical has ended its two-year long hostile attempt to take over Circon. The decision was taken in light of US Surgical's proposed merger with Tyco International and the recent announcement from Santa Barbara, California-based Circon that it has invited various companies to make bids to acquire it (see Clinica Nos 823, p 7 & 810, pp 1-2). Tyco is a highly acquisitive company but not one which pursues hostile takeovers. Circon, which makes minimally-invasive equipment for urological and gynaecological procedures, welcomed the announcement from Norwalk, Connecticut-based US Surgical, which also produces minimally-invasive medical equipment.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.